RT Journal Article
T1 Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
A1 Bonanad, Clara
A1 Esteve Claramunt, Francisca
A1 García Blas, Sergio
A1 Ayesta, Ana
A1 Díez Villanueva, Pablo
A1 Pérez Rivera, Jose-Ángel
A1 Ferreiro, José Luis
A1 Cánoves, Joaquim
A1 López Fornás, Francisco
A1 Ariza Solé, Albert
A1 Raposerias, Sergio
A1 Vivas, David
A1 Blanco, Regina
A1 Bompart Berroterán, Daznia
A1 Cordero, Alberto
A1 Núñez, Julio
A1 Fácila, Lorenzo
A1 Núñez Gil, Iván J.
A1 Górriz, José Luis
A1 Bodí, Vicente
A1 Martínez Sellés d'Oliveira Soares, Manuel
A1 Ruiz Nodar, Juan Miguel
A1 Chorro, Francisco Javier
AB The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.
PB MPDI
SN 2077-0383
YR 2022
FD 2022-05-26
LK https://hdl.handle.net/20.500.14352/71726
UL https://hdl.handle.net/20.500.14352/71726
LA eng
NO Instituto de Salud Carlos III (ISCIII)/ FEDER
NO Conselleria de Educación—Generalitat Valencia
DS Docta Complutense
RD 27 abr 2024